Stereotaxis (FRA:RJR1) EV-to-EBIT : -6.76 (As of May. 30, 2025)

Stereotaxis EV-to-EBIT Chart

Stereotaxis Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					-50.82	-33.80	-7.35	-6.09	-7.83

Stereotaxis Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															-9.90	-6.77	-7.75	-7.83	-5.86

Competitive Comparison of Stereotaxis's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Stereotaxis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stereotaxis's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Stereotaxis's EV-to-EBIT falls into.

Stereotaxis EV-to-EBIT Calculation

Stereotaxis's EV-to-EBIT for today is calculated as:

Stereotaxis's current Enterprise Value is €162.82 Mil.
Stereotaxis's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-24.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stereotaxis  (FRA:RJR1) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Stereotaxis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Stereotaxis's Enterprise Value for the quarter that ended in Mar. 2025 was €139.81 Mil.
Stereotaxis's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-24.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stereotaxis EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Stereotaxis's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Stereotaxis Business Description